Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > News > ORNL nanoscience center 'Jump Starts' medical compound device

May 24th, 2005

ORNL nanoscience center 'Jump Starts' medical compound device

Abstract:
A device that could create custom-tailored medical compounds faster than ever before is one of the first projects launched under the new Center for Nanophase Materials Science at Oak Ridge National Laboratory.

Project director Joseph Matteo, founder and CEO of the local research firm NanoTek, is building a small, microfluidic machine to quickly and reliably synthesize drugs, medicines, diagnostic imaging agents and other compounds.

His work is part of the CNMS Jump Start Program, which gives selected nanoscience projects access to ORNL research facilities and staff before the center begins full operation in October.

The program includes more than 75 research proposals, all of which are evaluated by an external scientific review committee, selected for scientific merit and quality, and will be published in the scientific press.

Source:
ORNL

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

Center for Nanophase Materials Science

Related News Press

Possible Futures

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project